• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种免疫浸润特征可预测结肠癌患者的总生存期。

An immune infiltration signature to predict the overall survival of patients with colon cancer.

机构信息

Department of the First Surgery, The Central Hospital of Enshi Autonomous Prefecture, Enshi, China.

出版信息

IUBMB Life. 2019 Nov;71(11):1760-1770. doi: 10.1002/iub.2124. Epub 2019 Jul 13.

DOI:10.1002/iub.2124
PMID:31301220
Abstract

Immune infiltration of tumors has been increasingly accepted as a prognostic factor in colon cancer. Here, we aim to develop a novel immune signature, based on estimated immune landscape from tumor transcriptomes, to predict the overall survival of patients with colon cancer. The compositions of 22 immune cell subtypes from three microarray datasets were characterized with the CIBERSORT deconvolution algorithm. A prognostic immunoscore (PIS) model for overall survival prediction was established by using least absolute shrinkage and selection operator (LASSO) penalized regression analysis. A total of 17 immune cell markers were screened out in the LASSO model and were then aggregated to generate the PIS. In the training cohort (n = 490), patients with high PIS exhibited a remarkably poorer overall survival than those with low PIS. Similar results were obtained in patients with different TNM stages and in patients receiving adjunctive chemotherapy or not. Multivariate Cox regression indicated that the PIS was an independent predictor for overall survival in colon cancer (hazard ratio: 2.734, 95% confidence interval: 2.052-3.643, p < .001). The prognostic capability of PIS was also confirmed in the testing cohort (n = 245) and the entire cohort (n = 735). As for biological implications, the PIS was significantly associated with some immune checkpoints, inflammatory factors, epithelial-mesenchymal transformation regulators, and many known signaling pathways in cancer. The results of our study provide a novel and promising immune signature for overall survival prediction of patients with colon cancer.

摘要

肿瘤的免疫浸润已被越来越多地认为是结肠癌的预后因素。在这里,我们旨在基于肿瘤转录组估计的免疫景观,开发一种新的免疫特征,以预测结肠癌患者的总生存率。使用 CIBERSORT 去卷积算法对来自三个微阵列数据集的 22 种免疫细胞亚型的组成进行了表征。通过使用最小绝对收缩和选择算子 (LASSO) 惩罚回归分析建立了用于总体生存预测的预后免疫评分 (PIS) 模型。在 LASSO 模型中筛选出 17 个免疫细胞标记物,并将其聚集以生成 PIS。在训练队列 (n = 490) 中,PIS 高的患者总生存率明显低于 PIS 低的患者。在不同 TNM 分期的患者和接受辅助化疗或不接受辅助化疗的患者中也得到了类似的结果。多变量 Cox 回归表明,PIS 是结肠癌总生存的独立预测因子 (危险比:2.734,95%置信区间:2.052-3.643,p < 0.001)。PIS 的预后能力也在测试队列 (n = 245) 和整个队列 (n = 735) 中得到了证实。就生物学意义而言,PIS 与一些免疫检查点、炎症因子、上皮-间充质转化调节剂以及癌症中的许多已知信号通路显著相关。我们的研究结果为预测结肠癌患者的总体生存率提供了一种新的、有前途的免疫特征。

相似文献

1
An immune infiltration signature to predict the overall survival of patients with colon cancer.一种免疫浸润特征可预测结肠癌患者的总生存期。
IUBMB Life. 2019 Nov;71(11):1760-1770. doi: 10.1002/iub.2124. Epub 2019 Jul 13.
2
Gene expression profiles for a prognostic immunoscore in gastric cancer.胃癌预后免疫评分的基因表达谱。
Br J Surg. 2018 Sep;105(10):1338-1348. doi: 10.1002/bjs.10871. Epub 2018 Apr 25.
3
Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.鉴定预测结肠癌预后风险和淋巴细胞浸润的免疫特征。
Front Immunol. 2020 Sep 3;11:1678. doi: 10.3389/fimmu.2020.01678. eCollection 2020.
4
Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer.免疫细胞浸润作为 I-III 期结肠癌诊断和预后的生物标志物。
Cancer Immunol Immunother. 2019 Mar;68(3):433-442. doi: 10.1007/s00262-018-2289-7. Epub 2018 Dec 19.
5
Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma.基于炎症相关基因的结肠腺癌分子亚型鉴定和预后标志物。
Front Immunol. 2021 Dec 23;12:769685. doi: 10.3389/fimmu.2021.769685. eCollection 2021.
6
A Prognostic Immunoscore for Relapse-Free Survival Prediction in Colorectal Cancer.结直肠癌无复发生存预测的预后免疫评分。
DNA Cell Biol. 2020 Jul;39(7):1181-1193. doi: 10.1089/dna.2020.5490. Epub 2020 May 12.
7
A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer.基于肿瘤微环境基因的稳健面板,用于预测 I-III 期结肠癌的预后并制定治疗方案。
EBioMedicine. 2019 Apr;42:420-430. doi: 10.1016/j.ebiom.2019.03.043. Epub 2019 Mar 24.
8
Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.肿瘤浸润免疫细胞对乙型肝炎病毒相关性肝细胞癌预后预测的意义。
World J Gastroenterol. 2019 Sep 21;25(35):5266-5282. doi: 10.3748/wjg.v25.i35.5266.
9
Identification and validation of an immune-related gene signature predictive of overall survival in colon cancer.鉴定和验证一个与免疫相关的基因特征,可预测结肠癌的总生存期。
Aging (Albany NY). 2020 Dec 19;12(24):26095-26120. doi: 10.18632/aging.202317.
10
A comprehensive analysis of tumor microenvironment-related genes in colon cancer.结肠癌肿瘤微环境相关基因的综合分析。
Clin Transl Oncol. 2021 Sep;23(9):1769-1781. doi: 10.1007/s12094-021-02578-w. Epub 2021 Mar 10.

引用本文的文献

1
LARS2 DNA methylation predicts the prognosis in colon cancer.LARS2基因的DNA甲基化可预测结肠癌的预后。
Sci Rep. 2025 Jul 22;15(1):26542. doi: 10.1038/s41598-025-10669-9.
2
Unveiling the prognostic significance of RNA editing-related genes in colon cancer: evidence from bioinformatics and experiment.揭示RNA编辑相关基因在结肠癌中的预后意义:来自生物信息学和实验的证据
Eur J Med Res. 2025 Feb 12;30(1):94. doi: 10.1186/s40001-025-02335-7.
3
Identification and validation of a prognostic signature based on six immune-related genes for colorectal cancer.
基于六个免疫相关基因的结直肠癌预后标志物的鉴定与验证
Discov Oncol. 2024 May 28;15(1):192. doi: 10.1007/s12672-024-01058-1.
4
Identification and validation of mitophagy-related signatures as a novel prognostic model for colorectal cancer.鉴定和验证线粒体自噬相关特征作为结直肠癌的一种新型预后模型
Transl Cancer Res. 2024 Feb 29;13(2):782-797. doi: 10.21037/tcr-23-785. Epub 2024 Feb 26.
5
Machine learning algorithm to construct cuproptosis- and immune-related prognosis prediction model for colon cancer.构建结肠癌铜死亡和免疫相关预后预测模型的机器学习算法
World J Gastrointest Oncol. 2023 Mar 15;15(3):372-388. doi: 10.4251/wjgo.v15.i3.372.
6
A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.与结直肠癌预后和免疫微环境相关的自噬相关基因特征。
Sci Rep. 2022 Nov 4;12(1):18688. doi: 10.1038/s41598-022-23463-8.
7
Identification of RUNX1 and IFNGR2 as prognostic-related biomarkers correlated with immune infiltration and subtype differentiation of low-grade glioma.鉴定 RUNX1 和 IFNGR2 作为与低级别胶质瘤免疫浸润和亚型分化相关的预后相关生物标志物。
Biomol Biomed. 2023 May 1;23(3):405-425. doi: 10.17305/bjbms.2022.8086.
8
An Immune-Related Prognostic Risk Model in Colon Cancer by Bioinformatics Analysis.通过生物信息学分析建立的结肠癌免疫相关预后风险模型
Evid Based Complement Alternat Med. 2022 Aug 27;2022:3640589. doi: 10.1155/2022/3640589. eCollection 2022.
9
Immune-Related LncRNAs to Construct a Prognosis Risk-Assessment Model for Gastric Cancer.免疫相关长链非编码 RNA 构建胃癌预后风险评估模型。
Curr Oncol. 2022 Jul 12;29(7):4923-4935. doi: 10.3390/curroncol29070391.
10
ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis.基于单细胞RNA测序分析,ASCL2影响结肠腺癌免疫治疗的疗效。
Front Immunol. 2022 Jun 3;13:829640. doi: 10.3389/fimmu.2022.829640. eCollection 2022.